Two Seas Capital LP has filed a Form 13F-HR with the Securities and Exchange Commission, disclosing its equity securities holdings as of the close of business on September 30, 2026. The filing, signed by Chief Financial Officer Lawrence V. Palermo on October 6, 2026, lists the firm's positions in 47 different companies.
The portfolio includes a mix of large-cap technology and biotechnology firms, as well as energy companies and exchange-traded funds. Among the notable holdings is Applied Digital Corporation, where the firm holds 50,000 shares. The firm also holds significant positions in Applied Materials, with 377,984 shares, and Applied Therapeutics, with 1,490,992 shares.
Biotechnology companies represent a substantial portion of the portfolio. Two Seas Capital holds 8,143,994 shares of Arbutus Biopharma Corp. and 7,325,356 shares of Roivant Sciences Ltd. The firm also holds 4,612,692 shares of Immunovant Inc. and 3,345,978 shares of Nektar Therapeutics.
In the energy sector, the firm holds 17,101,876 shares of Sable Offshore Corp. and 5,35,493 shares of Talen Energy Corp. The firm also holds 2,712,60 shares of FTAI Aviation Ltd. and 1,200,679 shares of Golar LNG Ltd.
The filing also includes positions in several exchange-traded funds, including the Invesco QQQ Trust (5,393,000 shares), the iShares Russell 2000 ETF (2,477,700 shares), and the State Street SPDR S&P 500 ETF (1,490,000 shares).
The filing lists a total of 47 holdings, with the largest position being USA Today Co. Inc., which holds 14,504,707 shares.
